# Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression

> **NCT03507608** · EARLY_PHASE1 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 25 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Flutamide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03507608
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-10
- **Primary completion:** 2024-09-30
- **Final completion:** 2025-07-03
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03507608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03507608, "Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03507608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*